Potential hazards in the analysis of symptom improvement

Lung Cancer. 2003 May;40(2):201-2. doi: 10.1016/s0169-5002(03)00074-6.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Editorial

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Quality of Life
  • Survival Rate
  • Treatment Outcome